P4 Therapeutics aims at establishing a sustainable and long-lasting R & D organization in Austria. Being located in Vienna, Austria, P4 Therapeutics will run additional R&D activities to continuously improve Albuplatin in order to sustainably expand and shape the field of application of albumin-binding cancer therapeutics.

ab&cd innovations is engaged in the challenge to develope procedures for extracting chemicals and recyclables from processed remnants / byproducts as well as from biomass.

ISOtopic solutions offers a blend of stable isotope labeled biomolecules as an internal standard for mass spectrometry, as well as individual process consulting and analytical services.